1
|
[Development of an information website on the proper use of medicines during the pandemic]. ACTUALITES PHARMACEUTIQUES 2020; 59:34-39. [PMID: 33100495 PMCID: PMC7574859 DOI: 10.1016/j.actpha.2020.08.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
In the context of COVID-19, the French Society of Pharmacology and Therapeutics opened a question-and-answer website on 17 March 2020 to provide clear and reliable answers to patients' questions about the treatment of their chronic pathologies, to inform the general public about the proper use of medicines and to fight against misinformation. On May 13, 152 questions and answers were published and updated on this website, which was visited more than 154,000 times in two months.
Collapse
|
2
|
Larrouquere L, Gabin M, Poingt E, Mouffak A, Hlavaty A, Lepelley M, Khouri C, Bellier A, Alexandre J, Bedouch P, Bertoletti L, Bordet R, Bouhanick B, Jonville-Bera AP, Laporte S, Le Jeunne C, Letinier L, Micallef J, Naudet F, Roustit M, Molimard M, Richard V, Cracowski JL. Genesis of an emergency public drug information website by the French Society of Pharmacology and Therapeutics during the COVID-19 pandemic. Fundam Clin Pharmacol 2020; 34:389-396. [PMID: 32394481 PMCID: PMC7273039 DOI: 10.1111/fcp.12564] [Citation(s) in RCA: 19] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/01/2020] [Revised: 05/05/2020] [Accepted: 05/06/2020] [Indexed: 12/27/2022]
Abstract
On March 16, 2020, the French Society of Pharmacology and Therapeutics put online a national Question and Answer (Q&A) website, https://sfpt-fr.org/covid19 on the proper use of drugs during the COVID‐19 pandemic. The working group ‘Drugs and COVID‐19’ was composed of a scientific council, an editorial team, and experts in the field. The first questions were posted online during the first evening of home‐confinement in France, March 17, 2020. Six weeks later, 140 Q&As have been posted. Questions on the controversial use of hydroxychloroquine and to a lesser extent concerning azithromycin have been the most consulted Q&As. Q&As have been consulted 226 014 times in 41 days. This large visibility was obtained through an early communication on Twitter, Facebook, traditional print, and web media. In addition, an early communication through the French Ministry of Health and the French National Agency for Medicines and Health Products Safety ANSM had a large impact in terms of daily number of views. There is a pressing need to sustain a public drug information service combining the expertise of scholarly pharmacology societies, pharmacovigilance network, and the Ministry of Health to quickly provide understandable, clear, expert answers to the general population’s concerns regarding COVID‐19 and drug use and to counter fake news.
Collapse
Affiliation(s)
| | - Manon Gabin
- Univ. Grenoble Alpes, CHU Grenoble Alpes, Grenoble, France
| | | | - Amelle Mouffak
- Univ. Grenoble Alpes, CHU Grenoble Alpes, Grenoble, France
| | - Alex Hlavaty
- Univ. Grenoble Alpes, CHU Grenoble Alpes, Grenoble, France
| | | | - Charles Khouri
- Univ. Grenoble Alpes, CHU Grenoble Alpes, Grenoble, France
| | | | | | | | | | | | | | | | - Silvy Laporte
- Univ. Saint Etienne, CHU Saint Etienne, Saint Etienne, France
| | | | | | - Joëlle Micallef
- Aix-Marseille Université, Hôpitaux Universitaires de Marseille - APHM, Marseille, France
| | | | | | | | | | | |
Collapse
|